{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:51:57Z","timestamp":1791229917410,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejso.2020.10.029","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T04:29:23Z","timestamp":1604291363000},"page":"942-951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)"],"prefix":"10.1016","volume":"47","author":[{"given":"Milena","family":"Rond\u00f3n-Lagos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Camargo-Villalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5205-8891","authenticated-orcid":false,"given":"Maribel","family":"Forero-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.10.029_bib1","series-title":"Device reports of breast implant-associated anaplastic large cell lymphoma","author":"Medical","year":"2019"},{"key":"10.1016\/j.ejso.2020.10.029_bib2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006534-199708000-00065","article-title":"Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant","volume":"100","author":"Keech","year":"1997","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1090820X11407872","article-title":"Anaplastic large cell lymphoma and breast implants: FDA report","volume":"31","author":"Eaves","year":"2011","journal-title":"Aesthetic Surg J"},{"key":"10.1016\/j.ejso.2020.10.029_bib4","year":"2020","journal-title":"ASoPS. BIA-ALCL Physician Resources"},{"key":"10.1016\/j.ejso.2020.10.029_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181097","article-title":"Cytological diagnostic features of late breast implant seromas: from reactive to anaplastic large cell lymphoma","volume":"12","author":"Di Napoli","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.ejso.2020.10.029_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/PRS.0000000000003933","article-title":"MBN 2016 aesthetic breast meeting BIA-ALCL consensus conference report","volume":"141","author":"Nava","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoncol.2017.4510","article-title":"Breast implants and the risk of anaplastic large-cell lymphoma in the breast","volume":"4","author":"de Boer","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2020.10.029_bib8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/PRS.0000000000003282","article-title":"U.S. Epidemiology of breast implant-associated anaplastic large cell lymphoma","volume":"139","author":"Doren","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bjps.2019.11.064","article-title":"Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants","volume":"73","author":"Cordeiro","year":"2020","journal-title":"J\u00a0Plast Reconstr Aesthetic Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib10","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/PAS.0b013e31825749b1","article-title":"Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases","volume":"36","author":"Aladily","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2020.10.029_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.10.029_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.21037\/gs.2016.11.03","article-title":"Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules","volume":"6","author":"Clemens","year":"2017","journal-title":"Gland Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0000000000004262","article-title":"How to diagnose and treat breast implant-associated anaplastic large cell lymphoma","volume":"141","author":"Clemens","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib14","first-page":"628","article-title":"Breast implant-associated lymphoma","volume":"115","author":"Kricheldorff","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.ejso.2020.10.029_bib15","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/asj\/sjy331","article-title":"NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"39","author":"Clemens","year":"2019","journal-title":"Aesthetic Surg J"},{"key":"10.1016\/j.ejso.2020.10.029_bib16","volume":"vol. 2","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.ejso.2020.10.029_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3324\/haematol.2009.008250","article-title":"Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy","volume":"94","author":"Falini","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.ejso.2020.10.029_bib18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/annonc\/mdv575","article-title":"Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes","volume":"27","author":"Laurent","year":"2016","journal-title":"Ann Oncol : official journal of the European Society for Medical Oncology \/ ESMO"},{"key":"10.1016\/j.ejso.2020.10.029_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAI.0b013e318266476c","article-title":"Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases","volume":"21","author":"Taylor","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ejso.2020.10.029_bib20","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1093\/asj\/sjy229","article-title":"The cellular origins of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): implications for immunogenesis","volume":"39","author":"Turner","year":"2019","journal-title":"Aesthetic Surg J"},{"key":"10.1016\/j.ejso.2020.10.029_bib21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/PRS.0000000000003654","article-title":"Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk","volume":"140","author":"Loch-Wilkinson","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib22","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/PRS.0000000000002010","article-title":"Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma","volume":"137","author":"Hu","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/PRS.0000000000000886","article-title":"Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma","volume":"135","author":"Hu","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib24","article-title":"22 cases of breast implant-associated ALCL: awareness and outcome tracking from the Italian ministry of Health","volume":"141","author":"Campanale","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/PRS.0000000000003575","article-title":"Macrotextured breast implants with defined steps to minimize bacterial contamination around the device: experience in 42,000 implants","volume":"140","author":"Adams","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib26","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1038\/s41598-019-46535-8","article-title":"Insights into the microbiome of breast implants and periprosthetic tissue in breast implant-associated anaplastic large cell lymphoma","volume":"9","author":"Walker","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2020.10.029_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/156652310790945575","article-title":"Tumour targeting with systemically administered bacteria","volume":"10","author":"Morrissey","year":"2010","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.ejso.2020.10.029_bib28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/PRS.0000000000003712","article-title":"Discussion: breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk","volume":"140","author":"Myckatyn","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041171","article-title":"Current approaches including novel nano\/microtechniques to reduce silicone implant-induced contracture with adverse immune responses","volume":"19","author":"Kang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejso.2020.10.029_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0b013e31823aeacf","article-title":"T\u00a0regulatory cells and TH17 cells in peri-silicone implant capsular fibrosis","volume":"129","author":"Wolfram","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jbm.820220805","article-title":"Human monocyte\/macrophage activation and interleukin 1 generation by biomedical polymers","volume":"22","author":"Miller","year":"1988","journal-title":"J\u00a0Biomed Mater Res"},{"key":"10.1016\/j.ejso.2020.10.029_bib32","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","article-title":"Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors","volume":"19","author":"Hirano","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ejso.2020.10.029_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235050","article-title":"Silicone induced granuloma of breast implant capsule (SIGBIC) diagnosis: breast magnetic resonance (BMR) sensitivity to detect silicone bleeding","volume":"15","author":"Fleury","year":"2020","journal-title":"PloS One"},{"issue":"43","key":"10.1016\/j.ejso.2020.10.029_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00238-019-01612-z","article-title":"Clear to cloudy II: radiological perspective of silicone breast implants","volume":"43","author":"Fleury","year":"2020","journal-title":"Eur J Plast Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib35","doi-asserted-by":"crossref","first-page":"36126","DOI":"10.18632\/oncotarget.26308","article-title":"Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma","volume":"9","author":"Blombery","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejso.2020.10.029_bib36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bjh.14431","article-title":"Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK\/STAT signalling pathway genes, TP53 and DNMT3A","volume":"180","author":"Di Napoli","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejso.2020.10.029_bib37","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2017-12-821868","article-title":"Genetic subtyping of breast implant-associated anaplastic large cell lymphoma","volume":"132","author":"Oishi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ejso.2020.10.029_bib38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00428-018-2352-y","article-title":"Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma","volume":"473","author":"Letourneau","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ejso.2020.10.029_bib39","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.3324\/haematol.2016.146118","article-title":"Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma","volume":"101","author":"Blombery","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.ejso.2020.10.029_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13000-018-0688-x","article-title":"Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report","volume":"13","author":"Pastorello","year":"2018","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.ejso.2020.10.029_bib41","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/his.12737","article-title":"Breast implant-associated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndrome","volume":"67","author":"Lee","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2020.10.029_bib42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1182\/blood-2014-08-594507","article-title":"Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma","volume":"125","author":"Weilemann","year":"2015","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ejso.2020.10.029_bib43","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2019004498","article-title":"Increased prevalence of BRCA1\/2 mutations in women with macro-textured breast implants and anaplastic large cell lymphoma of the breast","volume":"136","author":"De Boer","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ejso.2020.10.029_bib44","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK-STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ejso.2020.10.029_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semcancer.2017.03.006","article-title":"Mechanisms governing metastatic dormancy in breast cancer","volume":"44","author":"Dittmer","year":"2017","journal-title":"Semin Canc Biol"},{"key":"10.1016\/j.ejso.2020.10.029_bib46","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Canc Cell"},{"key":"10.1016\/j.ejso.2020.10.029_bib47","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/asj\/sjw023","article-title":"Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma","volume":"36","author":"Kadin","year":"2016","journal-title":"Aesthetic Surg J"},{"key":"10.1016\/j.ejso.2020.10.029_bib48","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1158\/1078-0432.CCR-12-0101","article-title":"Survival signals and targets for therapy in breast implant-associated ALK-anaplastic large cell lymphoma","volume":"18","author":"Lechner","year":"2012","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.ejso.2020.10.029_bib49","first-page":"360","article-title":"Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL","volume":"135","author":"Laurent","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ejso.2020.10.029_bib50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A\u00a0targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejso.2020.10.029_bib51","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2020.10.029_bib52","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2009-06-225839","article-title":"Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities","volume":"114","author":"Mottok","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejso.2020.10.029_bib53","doi-asserted-by":"crossref","first-page":"59S","DOI":"10.1097\/PRS.0000000000005570","article-title":"Molecular drivers of breast implant-associated anaplastic large cell lymphoma","volume":"143","author":"Blombery","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cyto.2015.10.015","article-title":"Tyrosine kinase 2 - surveillant of tumours and bona fide oncogene","volume":"89","author":"Leitner","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.ejso.2020.10.029_bib55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","article-title":"The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells","volume":"15","author":"Seif","year":"2017","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.ejso.2020.10.029_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(05)70434-4","article-title":"Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium","volume":"7","author":"Rothman","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2020.10.029_bib57","first-page":"1222","article-title":"Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin\u2019s lymphoma","volume":"91","author":"Lightfoot","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.ejso.2020.10.029_bib58","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00428-019-02570-4","article-title":"Systemic, primary cutaneous, and breast implant-associated ALK-negative anaplastic large-cell lymphomas present similar biologic features despite distinct clinical behavior","volume":"475","author":"Gerbe","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ejso.2020.10.029_bib59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/leu.2016.263","article-title":"The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases","volume":"31","author":"Stengel","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.ejso.2020.10.029_bib60","first-page":"1413","article-title":"Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma","volume":"39","author":"Stefancikova","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ejso.2020.10.029_bib61","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.4049\/jimmunol.1300744","article-title":"Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM\/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming","volume":"191","author":"Marzec","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ejso.2020.10.029_bib62","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ejso.2020.10.029_bib63","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrc3895","article-title":"DNMT3A in haematological malignancies","volume":"15","author":"Yang","year":"2015","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.ejso.2020.10.029_bib64","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpba.2014.09.008","article-title":"Chemical fingerprinting of silicone-based breast implants","volume":"102","author":"Keizers","year":"2015","journal-title":"J\u00a0Pharmaceut Biomed Anal"},{"key":"10.1016\/j.ejso.2020.10.029_bib65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpba.2013.01.040","article-title":"Chemical and physicochemical properties of the high cohesive silicone gel from Poly Implant Prothese (PIP) breast prostheses after explantation: a preliminary, comparative analytical investigation","volume":"78\u201379","author":"Beretta","year":"2013","journal-title":"J\u00a0Pharmaceut Biomed Anal"},{"key":"10.1016\/j.ejso.2020.10.029_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jpba.2013.06.003","article-title":"Chemical and biochemical composition of late periprosthetic fluids from women after explantation of ruptured Poly Implant Prothese (PIP) breast prostheses","volume":"84","author":"Beretta","year":"2013","journal-title":"J\u00a0Pharmaceut Biomed Anal"},{"key":"10.1016\/j.ejso.2020.10.029_bib67","doi-asserted-by":"crossref","first-page":"163","DOI":"10.21037\/gs.2016.09.12","article-title":"Silicone breast implant rupture: a review","volume":"6","author":"Hillard","year":"2017","journal-title":"Gland Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.envint.2016.05.022","article-title":"Associations of urinary metal levels with serum hormones, spermatozoa apoptosis and sperm DNA damage in a Chinese population","volume":"94","author":"Wang","year":"2016","journal-title":"Environ Int"},{"key":"10.1016\/j.ejso.2020.10.029_bib69","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/10428190902795527","article-title":"Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement","volume":"50","author":"Alobeid","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejso.2020.10.029_bib70","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/cncr.25654","article-title":"Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity","volume":"117","author":"Lechner","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.10.029_bib71","first-page":"1631","article-title":"Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis","volume":"6","author":"George","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.ejso.2020.10.029_bib72","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41375-018-0239-1","article-title":"Dependency on the TYK2\/STAT1\/MCL1 axis in anaplastic large cell lymphoma","volume":"33","author":"Prutsch","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.ejso.2020.10.029_bib73","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1078-0432.CCR-10-2507","article-title":"Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL\/RANK\/OPG pathway in tumorigenesis and metastasis","volume":"18","author":"Dougall","year":"2012","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.ejso.2020.10.029_bib74","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nm.4118","article-title":"RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers","volume":"22","author":"Nolan","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2020.10.029_bib75","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2020.10.029_bib76","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","article-title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials","volume":"48","author":"Lipton","year":"2012","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2020.10.029_bib77","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.humpath.2019.05.007","article-title":"Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas","volume":"90","author":"Tabanelli","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2020.10.029_bib78","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/PAS.0000000000000983","article-title":"PD-L1 and PD-L2 are differentially expressed by macrophages or tumor cells in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"42","author":"Menguy","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2020.10.029_bib79","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hon.2375","article-title":"PD1 and PDL1 expression in primary central nervous system diffuse large B-cell lymphoma are frequent and expression of PD1 predicts poor survival","volume":"35","author":"Four","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.ejso.2020.10.029_bib80","article-title":"PD-1\/PD-L1 checkpoint in breast implant-associated anaplastic large cell lymphoma: a case report","volume":"3","author":"Antonella Bianchi","year":"2018","journal-title":"Biomed J Sci & Tech Res."},{"key":"10.1016\/j.ejso.2020.10.029_bib81","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejso.2020.10.029_bib82","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0b013e318221db96","article-title":"A\u00a0patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast","volume":"128","author":"Carty","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib83","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/PRS.0000000000001033","article-title":"Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases","volume":"135","author":"Brody","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejso.2020.10.029_bib84","article-title":"Breast implant-associated anaplastic large cell lymphoma affecting a neosubpectoral pocket","volume":"12","author":"Hobson","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ejso.2020.10.029_bib85","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/2292550320925906","article-title":"Breast implant-associated anaplastic large-cell lymphoma: current understanding and recommendations for management","volume":"28","author":"St Cyr","year":"2020","journal-title":"Plast Surg (Oakv)"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320308660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320308660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:36:31Z","timestamp":1760060191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320308660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0748798320308660"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.10.029","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}